SCM
ADCT icon

Sio Capital Management’s ADC Therapeutics ADCT Stock Holding History

Sio Capital Management’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,294,534
Closed -$2.96M – 44
2023
Q3 		$2.96M Sell
3,294,534
-726,171
-18% -$966K 0.91% 30
2023
Q2 		$8.64M Buy
4,020,705
+1,860,073
+86% +$4.18M 2.2% 13
2023
Q1 		$4.21M Buy
+2,160,632
New +$7.97M 2.08% 10

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCG
Vantage Consulting Group Virginia Beach, Virginia $19.7M AUM 280.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Sio Capital Management's ADCT Position: Q4 2023 in Review

Sio Capital Management sold out of ADC Therapeutics (ADCT) in Q4 2023, closing a stake of 3,294,534 shares — an estimated $2.96M sold.

Sio Capital Management first reported a position in ADCT in Q1 2023 and held it in 3 quarters. The position peaked at $8.64M in Q2 2023. 38 funds tracked by Wall St. Rank hold ADCT as of Q4 2023.

  • Sio Capital Management reported no remaining ADC Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Sio Capital Management sold 3,294,534 ADC Therapeutics shares in Q4 2023, an estimated $2.96M.
  • Sio Capital Management first reported a position in ADC Therapeutics in Q1 2023 and held it in 3 quarters.
  • Sio Capital Management's ADC Therapeutics position peaked at $8.64M in Q2 2023.
  • 38 funds tracked by Wall St. Rank held ADC Therapeutics as of Q4 2023.

Based on Sio Capital Management's 13F filing for Q4 2023, filed 13 Feb 2024.